MDWD MediWound Ltd.

NASDAQ
$13.84

MediWound Ltd. (MDWD) is expected to report earnings on November 19, 2026, before the market open. The consensus earnings estimate is a loss of $0.66 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -1.6% since its last earnings release on August 13, 2026.

MediWound Missed Consensus Estimates, Reaffirms
Thursday, August 13, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 19
Thursday · 7:00 AM ET
Earnings Whisper
-
vs ($0.66)
Rev est $8.71M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $13.27

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About MediWound Ltd.

MediWound Ltd. is the global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.